The FDA has approved a higher dose version of the GLP-1 drug Wegovy, which could lead to greater weight loss. The new dose is ...
The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer's disease and other causes of cognitive decline, providing a broader understanding of when the ...
Hims & Hers Health, Inc. (NYSE: HIMS) today announced that a broad assortment of Novo Nordisk’s FDA-approved GLP-1 medications are available to eligible customers, including the Wegovy® pill, which is ...
Like other weight loss drugs, the higher the dose, the more a person is likely to deal with side effects. More than 70% of ...
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. President Donald Trump listens as Dr. Marty Makary ...
Ryan Spak’s op-ed “FDA must do better for smokers trying to quit” (Sept. 16, TribLive) is a compelling and urgent call for the U.S. Food and Drug Administration to rethink its approach to helping ...
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...
WASHINGTON (AP) — The Food and Drug Administration on Tuesday approved a generic medication for a rare brain disorder, while walking back suggestions by President Donald Trump and other administration ...
Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. - Sarah Silbiger/Getty Images The US Food and Drug Administration has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results